Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma

被引：0
|
作者：
M. Reni
S. Cereda
E. Bonetto
M. G. Viganò
P. Passoni
A. Zerbi
G. Balzano
R. Nicoletti
C. Staudacher
V. Di Carlo
机构：
[1] San Raffaele Scientific Institute,Department of Oncology
[2] San Raffaele Scientific Institute,Department of Surgery
[3] San Raffaele Scientific Institute,Department of Radiology
来源：
Cancer Chemotherapy and Pharmacology | 2007年 / 59卷
关键词：
Pancreatic cancer; Chemotherapy; PEFG regimen; Dose-intense PEFG;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Docetaxel, cisplatin, and 5-fluorouracil compared with epirubicin, cisplatin, and 5-fluorouracil regimen for advanced gastric cancer: A systematic review and meta-analysis
    Li, Bo
    Chen, Lian
    Luo, Hong-Liang
    Yi, Feng-Ming
    Wei, Yi-Ping
    Zhang, Wen-Xiong
    [J]. WORLD JOURNAL OF CLINICAL CASES, 2019, 7 (05) : 600 - 615
  • [42] Definitive results of a phase II trial of PEF-G (cisplatin, epirubicin, 5-fluorouracil continous infusion, gemcitabine) in stage IV pancreatic adenocarcinoma.
    Reni, M
    Passoni, P
    Panucci, MG
    Villa, E
    [J]. ANNALS OF ONCOLOGY, 2000, 11 : 74 - 74
  • [43] 5-FLUOROURACIL VS EPIRUBICIN VS 5-FLUOROURACIL PLUS EPIRUBICIN IN ADVANCED GASTRIC-CARCINOMA
    LOEHRER, PJ
    HARRY, D
    CHLEBOWSKI, RT
    [J]. INVESTIGATIONAL NEW DRUGS, 1994, 12 (01) : 57 - 63
  • [44] A Phase 2 Trial of Gemcitabine, 5-Fluorouracil, and Radiation Therapy in Locally Advanced Nonmetastatic Pancreatic Adenocarcinoma
    Mamon, Harvey J.
    Niedzwiecki, Donna
    Hollis, Donna
    Tan, Benjamin R.
    Mayer, Robert J.
    Tepper, Joel E.
    Goldberg, Richard M.
    Blackstock, A. William
    Fuchs, Charles S.
    [J]. CANCER, 2011, 117 (12) : 2620 - 2628
  • [45] COMBINATION CHEMOTHERAPY WITH ETOPOSIDE AND 5-FLUOROURACIL IN ADVANCED PANCREATIC ADENOCARCINOMA
    CHRISTIANSEN, NP
    KENNEDY, BJ
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1989, 12 (01): : 46 - 48
  • [46] Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial
    Reni, M
    Cordio, S
    Milandri, C
    Passoni, P
    Bonetto, E
    Oliani, C
    Luppi, G
    Nicoletti, R
    Galli, L
    Bordonaro, R
    Passardi, A
    Zerbi, A
    Balzano, G
    Aldrighetti, L
    Staudacher, C
    Villa, E
    Di Carlo, V
    [J]. LANCET ONCOLOGY, 2005, 6 (06): : 369 - 376
  • [47] COMPARISON OF SINGLE-AGENT EPIRUBICIN AND 5-FLUOROURACIL EPIRUBICIN MITOMYCIN IN PATIENTS WITH ADVANCED ADENOCARCINOMA OF THE PANCREAS
    TOPHAM, C
    GLEES, J
    COOMBES, RC
    [J]. ONCOLOGY, 1993, 50 : 78 - 83
  • [48] Concurrent Full Dose Gemcitabine versus Concurrent 5-Fluorouracil Chemoradiotherapy for Locally Advanced Pancreatic Cancer
    Rakhra, S. S.
    Chung, A.
    Helenowski, I.
    Mulcahy, M.
    Hayes, J.
    Small, W.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S337 - S337
  • [49] Effect of Adjuvant Gemcitabine Combined with Low-dose 5-Fluorouracil and Cisplatin Chemotherapy for Advanced Biliary Carcinoma
    Morine, Yuji
    Shimada, Mitsuo
    Ikemoto, Tetsuya
    Arakawa, Yusuke
    Iwahashi, Shuichi
    Saito, Yu
    Yamada, Shinichiro
    Imura, Satoru
    [J]. ANTICANCER RESEARCH, 2017, 37 (11) : 6421 - 6428
  • [50] Continuous infusion of 5-fluorouracil and low dose cisplatin infusion for the treatment of advanced and recurrent gastric adenocarcinoma
    Chung, YS
    Yamashita, Y
    Inoue, T
    Matsuoka, T
    Nakata, B
    Onoda, N
    Maeda, K
    Sawada, T
    Kato, Y
    Shirasaka, T
    Sowa, M
    [J]. CANCER, 1997, 80 (01) : 1 - 7
12345